Those studies which supported the role of survivin as a biomarker of lung cancer assessed protein expression by immunohistochemistry on tumor tissue specimens, or measured mRNA levels by PCR in blood samples or in circulating tumor cells. Here, BIRC5 is linked to neoplasm.